Ua ʻae ʻia ʻo Veyong no ʻelua mau lāʻau lāʻau veterinary hou o ka Papa II

1. ʻO ka nānā o nā lāʻau lapaʻau lāʻau hou

Hoʻonohonoho papa inoa ʻana:> Papa II
Helu palapala hōʻoia inoa inoa lāʻau hou:
Tidiluoxin: (2021) Palapala Hoʻohui Lapaʻau ʻAilina Nūhou 23
Tidiluoxin Injection: (2021) Nānā Hou holoholona No. 24
Mea hana nui: Tidiluoxin
Ke kuleana a me ka hoʻohana: Macrolide antibiotics. Hoʻohana ʻia ia no ka mālama ʻana i nā maʻi hanu puaʻa i hoʻokumu ʻia e Actinobacillus pleuropneumoniae, Pasteurella multocida a me Haemophilus parasuis i maʻalahi iā Tediroxine.
Hoʻohana a me nā hana: hoʻokumu ʻia ma Taidiluoxin. Hoʻokomo Intramuscular: Hoʻokahi ka mahele, 4mg no 1kg kaumaha o ke kino, puaʻa (e like me ka 1ml injection o kēia huahana no 10kg kino kaupaona), hoʻohana hoʻokahi wale nō.

news-2-(3)

2.Mekanism o ka hana

ʻO Tadilosin kahi lāʻau antibiotic cyclohexanide 16-membered i hoʻolaʻa ʻia i nā holoholona semisynthetic, a like kona hopena antibacterial me ka tylosin, kahi e pale nui ai i ka elongation peptide chain a keʻakeʻa i ka synthesis o nā proteins bacterial e ka paʻa ʻana i ka 50S subunit o ka bacterial ribosome. Loaʻa iā ia kahi laulā antibacterial ākea a loaʻa kahi hopena bacteriostatic i nā hopena maikaʻi a me kekahi mau bacteria maikaʻi ʻole, keu hoʻi i nā pathogens respiratory, e like me Actinobacillus pleuropneumoniae, Pasteurella multocida, Bordetella bronchiseptica, Haemophilus parasuis, a me Streptococcus suis.
I kēia manawa, ʻo ka pilikia mua e kū nei i ka ʻoihana holoholona holoholona ma ka honua holoʻokoʻa ka maʻi nui a me ka make ʻana o nā maʻi hanu, me nā pohō waiwai i hoʻokumu ʻia e nā maʻi hanu a hiki i nā haneli miliona o yuan i kēlā me kēia makahiki. Hiki i ke kīʻī Tadiluoxin ke hāʻawi i ka papa holoʻokoʻa o ka mālama ʻana no ka pale ʻana a me ka mālama ʻana i nā maʻi maʻi hanu i hoʻokumu ʻia e nā koʻohune paʻakikī i nā puaʻa, a he hopena therapeutic loa ia i nā maʻi hanu i nā puaʻa. He nui nā mea maikaʻi e like me ka hoʻohana holoholona kūikawā, ʻoi aku ka liʻiliʻi o ke ana, ka papa holoʻokoʻa holoʻokoʻa me hoʻokahi hoʻomalu, lōʻihi hapalua o ke ola, ka bioavailability kiʻekiʻe a me nā koena haʻahaʻa.

news-2-(2)
news-2-(1)
news-2-(4)

3. Ka mea nui o R&D kūleʻa o nā lāʻau lāʻau hou i Veyong

Me ka hoʻomohala ʻana o ka ʻoihana hānau i koʻu ʻāina, ma lalo o nā kūlana o ka hoʻoulu nui a kiʻekiʻe, paʻakikī nā aʻa maʻi e hemo, maopopo ʻole nā ​​pathogens, a ʻaʻole pololei nā koho ʻana o nā lāʻau. Ua alakaʻi kēia mau mea āpau i ka hoʻonui ʻana o nā maʻi hanu i nā puaʻa, a lilo ia i mea ulu nui i ka ʻoihana puaʻa. Ua lawe nā pilikia i mea hōʻeha nui i ka mālama holoholona, ​​a ʻo ka pale ʻana a me ka mālama ʻana i nā maʻi hanu i kau nui ka manaʻo.

I kēia mau pōʻaiapili āpau, me ka loaʻa ʻana o ka palapala hōʻike lāʻau lāʻau hou, he hōʻoia ia o ka hana hou ʻana o ka hana ʻenehana ʻo Veyong, hoʻonui i ka hoʻopukapuka R & D, a me ka manaʻo nui i ka hoʻokomo ʻia ʻana o nā tālena. Kūlike ia me ka hoʻonohonoho ʻana o ka ʻoihana o nā hanu hanu, nā ʻōpū o ka ʻōpū, a me nā loea deworming. Kūlike ia he huahana koʻikoʻi kēia huahana i kēia manawa no ka pale ʻana a me ka mālama ʻana i nā maʻi hanu i nā puaʻa. Manaʻo ʻia e lilo ia i huahana huahana hou aʻe ma hope o ka huahana hōkū o ko Veyong respiratory respiratory i ka wā e hiki mai ana. He mea nui ia e hoʻonui ai i ka hoʻokūkū mākeke o ka ʻoihana a hoʻohui i ke kūlana o ka ʻoihana ma ke ʻano he loea hanu.


Ka manawa o ka manawa: Mei-15-2021